Diagnosis requires a combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can assist in matching the needs of a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individualised development of treatment programs for treatment and management of lymphoma of the lymphatic region, usually including drug therapy, rehabilitation interventions, regular follow-up, and multidimensional management.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of lymphomas in the peripheral region.
The platform serves a team of internationally authoritative experts in the field of blood tumours in China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.